Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Research And Trials

Computer programme could predict if immunotherapy will work

Combining information from different cancer scans could offer a way to predict if immunotherapy will work, according to a small unpublished study.

Meet our scientists investigating cancers’ weak spots, showing research ROCKs, and much more

We’d like to introduce the latest bunch of scientists that we’ve given funding to head up their own research teams for the first time.

Brain tumours’ shared metabolic tricks hint at new approach to treatment

Different types of brain tumours may share similar survival strategies, opening up new treatment research avenues.

Some aggressive ovarian cancers start in the fallopian tubes, not the ovaries

The most aggressive type of ovarian cancer develops from cells that come from the fallopian tubes rather than the ovaries, according to a small study.

Internal radiotherapy: tackling cancer from within

Radiotherapy doesn't have to be given from outside the body. Radioactive implants and drinks stay close to tumours to minimise side effects.

Researchers "drug the undruggable" through unique collaboration

A new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’, has been discovered through an alliance between industry and academia

Personalised treatments for rare cancers tested in study

A small new trial in the US has suggested personalised treatment based on tumour features could be effective in patients with rare cancers.

Our milestones: A radical change that improved breast cancer surgery

The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.

Taking part in clinical trials – Tommy’s story

In 2012, Tommy Brennan was diagnosed with bladder cancer. Here, he shares his story and his experience of joining a Cancer Research UK-funded clinical trial.

Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

Pages